abstract |
The present invention refers to thymoquinone, a main constituent of the volatile oil of Nigella sativa , and its protective effect against sepsis syndrome morbidity, mortality and associated organ dysfunctions. In particular, the present invention refers to thymoquinone for use in the prevention and/or treatment of sepsis syndrome. The present invention further refers to a pharmaceutical composition and a kit. |